Editorial Notes

[Editorial Notes] Embrace new health tech with due safeguards

Health technologies and innovation post COVID-19 provide an enabling infrastructure to strengthen Indian health system.
By IASToppers
July 23, 2020


  • Introduction
  • Concerns
  • Exacerbated risk
  • How to address the issue?
  • Conclusion

Embrace new health tech with due safeguards

For IASToppers’ Editorial Simplified Archive, click here


Since the spread of Covid-19, optimism in potential of health technologies to strengthen Indian health system has been evident. Much attention is focussed on digital contact tracing, technology-based interventions like portable ventilators, isolation pods, digital stethoscopes, devices to collect and dispose body fluids and robots to collect contagious waste etc. This has created an enabling infrastructure, providing fiscal incentives and easing regulatory processes to encourage innovation in health technologies.


  • The hasty adoption of new health technologies poses risk to patients and consumers of these technologies.
  • Harm may be caused due to defects in the technology, lack of training for health care workers, negligence in operating, and breaches of confidential personal data.
  • Recently, hospitals in Delhi and Mumbai flagged key defects in a set of low-cost ventilators of one manufacturer, and variance between the actual performance of the ventilator and performance registered on the device display.
  • The health care organisations have experienced a surge in medical data theft and ransomware attacks using digital medical devices.
  • Technology experts have warned against serious risks to personal privacy posed by Aarogya Setu, the Indian contact tracing mobile app.

Exacerbated Risk:

  • The risk is exacerbated because of the present regulatory processes involving the Indian Council of Medical Research and government approvals.
  • They are thin on detail, lack transparency and are unaccountable.
  • The health tech market is nascent, uncertain and rapidly evolving.
  • Some of the key barriers to the adoption of AI across industries are lack of skills to design, implement and maintain artificial intelligence (AI) solutions, and a lack of clarity on where to use such solutions effectively.
  • This raises a question that how can the regulatory framework governing health technologies encourage effective innovations without compromising patient safety and security?

How to address the issue?

1. Ethical principles:

  • At the centre of this debate are the ethical concerns rooted in the importance of harnessing health benefits as well as avoiding personal and social harm.
  • Health tech interventions should be guided by the consensus and articulation of ethical principles for public health.
  • They include: Right to privacy – recognised as a fundamental right under Articles 14, 19 and 21 of the Constitution of India by the Supreme Court of India in KS Puttaswamy vs Union of India (2017).
  • Other principles include: public oversight, minimising risk of error, facilitating equitable access, respecting individual autonomy and deploying the least burdensome alternative to accomplish the public health objective

2. Health Technology Assessment:

  • We need a comprehensive framework for evaluating health tech solutions.
  • Health Technology Assessment (HTA) is a recommended practice for assessing safety, cost and cost-effectiveness, social and organisational implications, legal and ethical considerations, clinical efficacy and effectiveness of a health tech solution.
  • India has the institutional setup for HTAs since 2017.
  • There is no publicly available evaluation of any of the health tech solutions implemented in the wake of the COVID-19 pandemic.
  • There is an urgent need to harness and augment this existing capacity.

3. Regulation:

  • Regulation of the health tech market should be accompanied with reforms in other areas of health care.
  • There are two aspects of regulation. One is ex-ante measures that mandate health care workers to undergo adequate training before operating a health tech application.
  • Additionally, an overarching data protection law will assuage privacy concerns related to digital medical data.
  • The other is ex-post measures that create liability in cases of deficiencies in a health tech application, inadequate training of health care workers, and mistakes or negligence in implementation.

4. Enabling atmosphere for innovation:

  • There is merit in mobilising technology to improve capacity in the Indian health system.
  • Hence, the government should facilitate an enabling environment for innovation in the health tech market.
  • This needs fiscal incentives and building capacity for early HTAs.
  • Early HTAs assess the potential added value of hypothetical health technologies that can inform decisions on earlier stages of product development.
  • Such evaluations will aid tech companies and research institutions to manage their product development portfolios while maximising societal benefits.
  • They will also accelerate the decision-making process of the government once the product is ready.


Successful implementation of any technological intervention, including health tech applications, is based on public trust and confidence. The Health Technology Assessment Board Bill 2019 is a step in the right direction. In its present form it lays out the structure, powers and functions of the board. It needs to be strengthened to institutionalise ethical systems for HTA analysis, keeping in mind the principles highlighted earlier.

Considering the rapid pace of development of the health tech market and its implications, the bill should be reinforced and prioritised in the coming parliament session.

Mains 2020 Editorial Notes

IT on Facebook

Facebook Pagelike Widget


Calendar Archive

October 2020
« Sep